Patents by Inventor Yuto Sumida

Yuto Sumida has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition for activating neurogenesis
    Patent number: 11318126
    Abstract: Provided is a composition for activating neurogenesis, use of the composition, and a method for preventing, improving, inhibiting the development of, and/or treating a disease or the like of the central nervous system and or the peripheral nervous system using the composition.
    Type: Grant
    Filed: August 31, 2017
    Date of Patent: May 3, 2022
    Assignee: Kyoto University
    Inventors: Masatoshi Hagiwara, Akiko Kobayashi, Takamitsu Hosoya, Suguru Yoshida, Yuto Sumida
  • COMPOSITION FOR ACTIVATING NEUROGENESIS
    Publication number: 20190247384
    Abstract: Provided is a composition for activating neurogenesis, use of the composition, and a method for preventing, improving, inhibiting the development of, and/or treating a disease or the like of the central nervous system and or the peripheral nervous system using the composition.
    Type: Application
    Filed: August 31, 2017
    Publication date: August 15, 2019
    Applicant: KYOTO UNIVERSITY
    Inventors: Masatoshi HAGIWARA, Akiko KOBAYASHI, Takamitsu HOSOYA, Suguru YOSHIDA, Yuto SUMIDA
  • Compound and pharmaceutical composition for neuropsychological disorder or malignant tumor
    Patent number: 10017524
    Abstract: The present invention provides a compound and a pharmaceutical composition for neuropsychological disorders or malignant tumors, the use of the compound and the pharmaceutical composition, or a method for preventing, improving, inhibiting the development of, and/or treating neuropsychological disorders or malignant tumors with the use of the compound and the pharmaceutical composition.
    Type: Grant
    Filed: July 26, 2017
    Date of Patent: July 10, 2018
    Assignees: KYOTO UNIVERSITY, NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY, KINOPHARMA, INC.
    Inventors: Masatoshi Hagiwara, Hiroshi Onogi, Isao Kii, Takamitsu Hosoya, Yuto Sumida
  • COMPOUND AND PHARMACEUTICAL COMPOSITION FOR NEUROPSYCHOLOGICAL DISORDER OR MALIGNANT TUMOR
    Publication number: 20170355715
    Abstract: The present invention provides a compound and a pharmaceutical composition for neuropsychological disorders or malignant tumors, the use of the compound and the pharmaceutical composition, or a method for preventing, improving, inhibiting the development of, and/or treating neuropsychological disorders or malignant tumors with the use of the compound and the pharmaceutical composition.
    Type: Application
    Filed: July 26, 2017
    Publication date: December 14, 2017
    Applicants: KYOTO UNIVERSITY, NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY, KINOPHARMA, INC.
    Inventors: Masatoshi HAGIWARA, Hiroshi ONOGI, Isao KII, Takamitsu HOSOYA, Yuto SUMIDA
  • Compound and pharmaceutical composition for neuropsychological disorder or malignant tumor
    Patent number: 9745323
    Abstract: The present invention provides a compound and a pharmaceutical composition for neuropsychological disorders or malignant tumors, the use of the compound and the pharmaceutical composition, or a method for preventing, improving, inhibiting the development of, and/or treating neuropsychological disorders or malignant tumors with the use of the compound and the pharmaceutical composition.
    Type: Grant
    Filed: July 30, 2013
    Date of Patent: August 29, 2017
    Assignees: KYOTO UNIVERSITY, NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY, KINOPHARMA, INC.
    Inventors: Masatoshi Hagiwara, Hiroshi Onogi, Isao Kii, Takamitsu Hosoya, Yuto Sumida
  • COMPOUND AND PHARMACEUTICAL COMPOSITION FOR NEUROPSYCHOLOGICAL DISORDER OR MALIGNANT TUMOR
    Publication number: 20150225421
    Abstract: The present invention provides a compound and a pharmaceutical composition for neuropsychological disorders or malignant tumors, the use of the compound and the pharmaceutical composition, or a method for preventing, improving, inhibiting the development of, and/or treating neuropsychological disorders or malignant tumors with the use of the compound and the pharmaceutical composition.
    Type: Application
    Filed: July 30, 2013
    Publication date: August 13, 2015
    Applicants: KYOTO UNIVERSITY, NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY, KINOPHARMA, INC.
    Inventors: Masatoshi Hagiwara, Hiroshi Onogi, Isao Kii, Takamitsu Hosoya, Yuto Sumida
  • SCREENING METHOD, PROTEIN INSTABILITY AND/OR STABILITY INDUCERS, AND PROTEIN ACTIVITY ASSESSMENT
    Publication number: 20150133467
    Abstract: Provided is a screening method with which it is possible to determine the cause of a decrease or an increase in the amount of a target protein that is expressed by a cell. One or a plurality of embodiments include: conducting cultivation that includes bringing an assay cell into contact with a test substance, and measuring a relative amount (A) of the target protein in relation to an internal standard; conducting cultivation in which an assay cell is not brought into contact with a test substance, and measuring a relative amount (B) in relation to an internal standard; comparing the relative amount (A) and the relative amount (B); and, based on the comparison, selecting a candidate substance that induces instability and/or stability in the target protein.
    Type: Application
    Filed: June 6, 2013
    Publication date: May 14, 2015
    Applicant: KYOTO UNIVERSITY
    Inventors: Masatoshi Hagiwara, lsao Kii, Takamitsu Hosoya, Yuto Sumida, Suguru Yoshida